CDER Compliance Office's Gray Retiring; ORA Advisor To Be Acting Director
Executive Summary
FDA Office of Regulatory Affairs Senior Advisor John Taylor will provide interim leadership to the Center of Drug Evaluation & Research's Compliance Office beginning April 18.
You may also be interested in...
CDER Compliance Office Head Horowitz Is Former Associate Chief Counsel
The Center for Drug Evaluation & Research Office of Compliance will be led by a director with experience in litigation and policy development rather than a background in the field offices.
CDER Compliance Office Head Horowitz Is Former Associate Chief Counsel
The Center for Drug Evaluation & Research Office of Compliance will be led by a director with experience in litigation and policy development rather than a background in the field offices.
CDER Deputy Director Williams Leaving FDA To Head U.S. Pharmacopeia
Center for Drug Evaluation & Research Deputy Director for Pharmaceutical Science Roger Williams, MD, will leave FDA to join U.S. Pharmacopeia Jan. 4.